SE8900243A - - Google Patents

Info

Publication number
SE8900243A
SE8900243A SE8900243A SE8900243A SE8900243A SE 8900243 A SE8900243 A SE 8900243A SE 8900243 A SE8900243 A SE 8900243A SE 8900243 A SE8900243 A SE 8900243A SE 8900243 A SE8900243 A SE 8900243A
Authority
SE
Sweden
Prior art keywords
antigens
neurocysticercosis
parasite
vitro
maintaining
Prior art date
Application number
SE8900243A
Other versions
SE8900243D0 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to SE19898900243A priority Critical patent/SE8900243D0/en
Publication of SE8900243D0 publication Critical patent/SE8900243D0/en
Publication of SE8900243A publication Critical patent/SE8900243A/xx
Priority to AU41429/89A priority patent/AU617526B2/en
Priority to GB8920931A priority patent/GB2223757B/en
Priority to CA000611731A priority patent/CA1340196C/en
Priority to GR900100011A priority patent/GR1000403B/en
Priority to EP90902417A priority patent/EP0456686B1/en
Priority to BR909007047A priority patent/BR9007047A/en
Priority to HU901472A priority patent/HUT56971A/en
Priority to DE69026076T priority patent/DE69026076D1/en
Priority to AT90902417T priority patent/ATE135823T1/en
Priority to PCT/SE1990/000034 priority patent/WO1990008958A1/en
Priority to JP2502737A priority patent/JPH04502814A/en
Priority to MX1915590A priority patent/MX19155A/en
Priority to CN90101000A priority patent/CN1045184A/en
Priority to PT92950A priority patent/PT92950A/en
Priority to KR1019900702121A priority patent/KR910700460A/en
Priority to OA60007A priority patent/OA09500A/en
Priority to NO912491A priority patent/NO912491D0/en
Priority to FI913530A priority patent/FI913530A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4355—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from cestodes
    • C07K14/43554—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from cestodes from Taenia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

Disclosed is a method of obtaining antigens of cysticercus cellulosae by maintaining the parasite in vitro. These antigens, used in an Enzyme Linked Immunosorbant Assay proved useful in detection of Neurocysticercosis cases.
SE19898900243A 1988-09-19 1989-01-24 A NOVEL IMMUNODIAGNOSTIC METHOD SE8900243D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE19898900243A SE8900243D0 (en) 1989-01-24 1989-01-24 A NOVEL IMMUNODIAGNOSTIC METHOD
AU41429/89A AU617526B2 (en) 1988-09-19 1989-09-15 A novel immunodiagnostic method
GB8920931A GB2223757B (en) 1988-09-19 1989-09-15 Excretory/secretory antigens of tapeworm (cysticerus cellulosae) for use in immunodiagnosis and vaccine preparation
CA000611731A CA1340196C (en) 1988-09-19 1989-09-18 Immunodiagnostic method for neurocysticercosis
GR900100011A GR1000403B (en) 1989-01-24 1990-01-09 New diagnostic method
PCT/SE1990/000034 WO1990008958A1 (en) 1989-01-24 1990-01-16 Excretory/secretory antigens of tapeworm (cysticercus cellulosae) for use in immunodiagnosis and vaccine preparation
BR909007047A BR9007047A (en) 1989-01-24 1990-01-16 ANTIGENS EXCRETORS / SECRETORS OF CYSTICERCUS CELLULOSAE, PROCESS FOR ITS OBTAINING AND FOR DIAGNOSIS OF ACTIVE HUMAN NCC
HU901472A HUT56971A (en) 1989-01-24 1990-01-16 A new method for diagnostics of immunity
JP2502737A JPH04502814A (en) 1989-01-24 1990-01-16 Novel immunodiagnostic method
EP90902417A EP0456686B1 (en) 1989-01-24 1990-01-16 Excretory/secretory antigens of tapeworm (cysticercus cellulosae) for use in immunodiagnosis and vaccine preparation
DE69026076T DE69026076D1 (en) 1989-01-24 1990-01-16 EXCLUSIVE / SECRETORIC ANTIGENS OF TAPEWORM (CYSTICERCUS CELLULOSAE) FOR USE IN IMMUNIAGNOSTICS AND VACCINE PREPARATION
AT90902417T ATE135823T1 (en) 1989-01-24 1990-01-16 TAPEWORM (CYSTICERCUS CELLULOSAE) EXCRETORY/SECRETORY ANTIGENS FOR USE IN IMMUNODIAGNOSTICS AND VACCINE PREPARATION
MX1915590A MX19155A (en) 1989-01-24 1990-01-17 METHOD FOR THE PREPARATION OF ANTIGENS OF CYSTICERCUS CELLULOSAE.
PT92950A PT92950A (en) 1989-01-24 1990-01-24 PROCESS FOR OBTAINING ANTIGENS FROM "CYSTICERCUS CELLULOSAS", VACCINES THAT CONTAIN THEM AND IMMUNODIAGNOSTIC METHOD USING THE ANTIGENS
CN90101000A CN1045184A (en) 1989-01-24 1990-01-24 A kind of new immune diagnostic method
KR1019900702121A KR910700460A (en) 1989-01-24 1990-09-24 Novel immunoassay
OA60007A OA09500A (en) 1989-01-24 1991-05-28 Excretory/secretory antigens of tapeworm (cysticercus cellulosae) for use in immunodiagnosis and vaccine preparation.
NO912491A NO912491D0 (en) 1989-01-24 1991-06-25 EXPRESSION / SECRECY ANTIGENES FROM BENDELORM (CYSTICERCUS CELLULOSAE) FOR USE IN IMMUNODIAGNOSTICS AND VACCINE MANUFACTURING.
FI913530A FI913530A0 (en) 1989-01-24 1991-07-23 EXCRETORIC / SECRETARY BANDMASK - (CYSTICERCUS CELLULOSAE) -ANTIGENER FOER ANVAENDNING I IMMUNODIAGNOSIS OCH VACCINATIONSPREPARAT.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19898900243A SE8900243D0 (en) 1989-01-24 1989-01-24 A NOVEL IMMUNODIAGNOSTIC METHOD

Publications (2)

Publication Number Publication Date
SE8900243A true SE8900243A (en) 1989-01-24
SE8900243D0 SE8900243D0 (en) 1989-01-24

Family

ID=20374839

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19898900243A SE8900243D0 (en) 1988-09-19 1989-01-24 A NOVEL IMMUNODIAGNOSTIC METHOD

Country Status (15)

Country Link
EP (1) EP0456686B1 (en)
JP (1) JPH04502814A (en)
KR (1) KR910700460A (en)
CN (1) CN1045184A (en)
AT (1) ATE135823T1 (en)
BR (1) BR9007047A (en)
DE (1) DE69026076D1 (en)
FI (1) FI913530A0 (en)
GR (1) GR1000403B (en)
HU (1) HUT56971A (en)
MX (1) MX19155A (en)
OA (1) OA09500A (en)
PT (1) PT92950A (en)
SE (1) SE8900243D0 (en)
WO (1) WO1990008958A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4614313B2 (en) * 2004-06-22 2011-01-19 学校法人北里研究所 Simple, quick and safe Q fever diagnostic method and diagnostic agent
CN101275140B (en) * 2007-12-27 2012-05-09 中国农业科学院兰州兽医研究所 Cysticercosis cellulosae recombination gene, vaccine and preparation thereof
JP5582521B2 (en) * 2009-04-10 2014-09-03 国立大学法人旭川医科大学 Purification method of antigen for cystosis diagnosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740456A (en) * 1985-08-15 1988-04-26 Wake Forest University Immunological methods for diagnosing neurocysticercosis

Also Published As

Publication number Publication date
KR910700460A (en) 1991-03-15
JPH04502814A (en) 1992-05-21
BR9007047A (en) 1991-11-12
GR900100011A (en) 1991-06-07
MX19155A (en) 1993-10-01
CN1045184A (en) 1990-09-05
EP0456686A1 (en) 1991-11-21
DE69026076D1 (en) 1996-04-25
EP0456686B1 (en) 1996-03-20
ATE135823T1 (en) 1996-04-15
GR1000403B (en) 1992-06-30
HUT56971A (en) 1991-10-28
OA09500A (en) 1992-11-15
SE8900243D0 (en) 1989-01-24
PT92950A (en) 1990-07-31
WO1990008958A1 (en) 1990-08-09
FI913530A0 (en) 1991-07-23

Similar Documents

Publication Publication Date Title
PL288271A1 (en) Method of obtaining an antigen combination
AU581082B2 (en) Immunoassay technique using displacement of antigen
AU2460988A (en) Simultaneous immunoassay for the determination of antigens and antibodies
EP0288082A3 (en) A tumor specific assay for ca125 ovarian cancer antigen
AU6852594A (en) Production of antibody fragments
ES2091463T3 (en) PROCEDURE FOR PREPARING IMIDAZO (4,5-C) QUINOLIN-4-AMINAS.
AU7262691A (en) Anabolic activity modulator and uses thereof
IN169762B (en)
EP0678744A3 (en) Method for detecting urinary tumor associated antigens.
AU7203687A (en) Method of assay of inhibin
GB2260609B (en) Separation and analysis
ZA855012B (en) A method for the preparation of yeast chromatin and its use for obtaining antibodies for the detection of mammalian carcinomas
SE8900243A (en)
AU590203B2 (en) Immunoassay for detection of common determinant antibody to hepatitis B
CA2161704A1 (en) Electrochemiluminescence assay
IL81689A0 (en) Competitive enzyme-linked immunosorbent assay method for the detection of antibodies
AU8059587A (en) A latex agglutination method for the detection of anti-streptococcal deoxyribonuclease B
AU3829189A (en) Detecting antigens or antibodies
CA2012740A1 (en) A monoclonal antibody recognizing c-terminus of anp
AU4948390A (en) Immunoassay method, reagent and kit
WO1987006617A3 (en) Detection of a unique chlamydia strain associated with acute respiratory disease
AU2484488A (en) Method for the production of antigenic protein-hapten conjugates, and antibodies corresponding thereto
AU7588787A (en) Preparation for immunoassay and method for producing the preparation
GB9211902D0 (en) Method of determining the allergenic response of a sample of mammalian blood to an antigen
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof